Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis - PubMed (original) (raw)
Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis
S V Ambudkar et al. Proc Natl Acad Sci U S A. 1992.
Abstract
Multidrug-resistant human tumor cells overexpress the MDR1 gene product P-glycoprotein, which is believed to function as an ATP-dependent efflux pump. In this study we demonstrate that the partially purified P-glycoprotein, when reconstituted in an artificial membrane, catalyzes drug-stimulated ATP hydrolysis. Plasma membrane proteins of a human multidrug-resistant cell line, KB-V1, were solubilized with 1.4% (wt/vol) octyl beta-D-glucopyranoside in the presence of 0.4% phospholipid and 20% (vol/vol) glycerol, and the crude detergent extract was chromatographed on DEAE-Sepharose CL-6B. The 0.1 M NaCl fraction, enriched in P-glycoprotein but devoid of Na,K-ATPase, was reconstituted by the detergent-dilution method. P-glycoprotein constituted 25-30% of the reconstituted protein in proteoliposomes. ATP hydrolysis by proteoliposomes was stimulated 3.5-fold by the addition of vinblastine but was unaffected by the hydrophobic antitumor agent camptothecin, which is not transported by P-glycoprotein. The stimulatory effect of vinblastine was observed only if the protein was reconstituted in proteoliposomes, suggesting that either the substrate binding site(s) was masked by detergent or that the conformation of the soluble P-glycoprotein might not be suitable for substrate-induced activation. Several other drugs that are known to be transported by P-glycoprotein enhanced the ATPase activity in a dose-dependent manner with relative potencies as follows: doxorubicin = vinblastine greater than daunomycin greater than actinomycin D greater than verapamil greater than colchicine. The basal and vinblastine-stimulated ATPase activities were inhibited by vanadate (50% inhibition observed at 7-10 microM) but were not affected by agents that inhibit other ATPases and phosphatases. These data indicate that the P-glycoprotein, similar to other ion-transporting ATPases, exhibits a high level of ATP hydrolysis (5-12 mumol per min per mg of protein).
Similar articles
- Purification and reconstitution of human P-glycoprotein.
Ambudkar SV, Lelong IH, Zhang J, Cardarelli C. Ambudkar SV, et al. Methods Enzymol. 1998;292:492-504. doi: 10.1016/s0076-6879(98)92038-9. Methods Enzymol. 1998. PMID: 9711577 - Purification and reconstitution of functional human P-glycoprotein.
Ambudkar SV. Ambudkar SV. J Bioenerg Biomembr. 1995 Feb;27(1):23-9. doi: 10.1007/BF02110327. J Bioenerg Biomembr. 1995. PMID: 7629047 Review. - Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
Doige CA, Sharom FJ. Doige CA, et al. Biochim Biophys Acta. 1992 Aug 24;1109(2):161-71. doi: 10.1016/0005-2736(92)90079-2. Biochim Biophys Acta. 1992. PMID: 1355667 - Characterization and functional reconstitution of the multidrug transporter.
Sharom FJ. Sharom FJ. J Bioenerg Biomembr. 1995 Feb;27(1):15-22. doi: 10.1007/BF02110326. J Bioenerg Biomembr. 1995. PMID: 7629046 Review.
Cited by
- Membrane Assays to Characterize Interaction of Drugs with ABCB1.
Fekete Z, Rajnai Z, Nagy T, Jakab KT, Kurunczi A, Gémes K, Herédi-Szabó K, Fülöp F, Tóth GK, Czerwinski M, Loewen G, Krajcsi P. Fekete Z, et al. J Membr Biol. 2015 Dec;248(6):967-77. doi: 10.1007/s00232-015-9804-y. Epub 2015 Apr 30. J Membr Biol. 2015. PMID: 25926125 - Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.
Goda K, Dönmez-Cakil Y, Tarapcsák S, Szalóki G, Szöllősi D, Parveen Z, Türk D, Szakács G, Chiba P, Stockner T. Goda K, et al. PLoS Genet. 2020 Oct 8;16(10):e1009016. doi: 10.1371/journal.pgen.1009016. eCollection 2020 Oct. PLoS Genet. 2020. PMID: 33031417 Free PMC article. - Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
Safa AR. Safa AR. Curr Med Chem Anticancer Agents. 2004 Jan;4(1):1-17. doi: 10.2174/1568011043482142. Curr Med Chem Anticancer Agents. 2004. PMID: 14754408 Free PMC article. Review. - Conformational changes in a multidrug resistance ABC transporter DrrAB: Fluorescence-based approaches to study substrate binding.
Rahman SJ, Kaur P. Rahman SJ, et al. Arch Biochem Biophys. 2018 Nov 15;658:31-45. doi: 10.1016/j.abb.2018.09.017. Epub 2018 Sep 20. Arch Biochem Biophys. 2018. PMID: 30243711 Free PMC article. - Molecular analysis of the multidrug transporter, P-glycoprotein.
Germann UA, Chambers TC. Germann UA, et al. Cytotechnology. 1998 Sep;27(1-3):31-60. doi: 10.1023/A:1008023629269. Cytotechnology. 1998. PMID: 19002782 Free PMC article.
References
- J Biol Chem. 1988 Mar 5;263(7):3067-70 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Annu Rev Biochem. 1989;58:137-71 - PubMed
- Mol Cell Biol. 1989 Dec;9(12):5289-97 - PubMed
- Proc Natl Acad Sci U S A. 1989 Sep;86(18):6953-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources